- Corporate Officers - Z
- Zanganeh Mahkam
Insider Trading History of Zanganeh Mahkam
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Zanganeh Mahkam since 2015.
This trader's CIK number is 1507650.
At the time of last reporting, Zanganeh Mahkam was the Co-Chief Executive Officer of Summit Therapeutics Inc.. (stock ticker symbol SMMT).
Also see all insider trading activities at Summit Therapeutics Inc..
Note that in the past
Zanganeh Mahkam also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pharmacyclics Inc (PCYC) by Zanganeh Mahkam
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | PCYC | 0 | $0 | 30,000 | $7,623,450 | 170,719 | $430,296 |
Yearly summary of insider trading at Pulse Biosciences, Inc. (PLSE) by Zanganeh Mahkam
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | PLSE | 0 | $0 | 0 | $0 | 76,075 | $162,800 |
| 2020 | PLSE | 9,143 | $68,496 | 0 | $0 | 0 | $0 |
| 2017 | PLSE | 148,665 | $2,892,119 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Summit Therapeutics Inc. (SMMT) by Zanganeh Mahkam
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | SMMT | 0 | $0 | 0 | $0 | 74,545 | $196,798 |
| 2024 | SMMT | 110,321 | $411,053 | 0 | $0 | 0 | $0 |
| 2023 | SMMT | 23,532,044 | $24,713,746 | 0 | $0 | 0 | $0 |
| 2022 | SMMT | 5,809,132 | $5,634,858 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Zanganeh Mahkam:
1. Pharmacyclics Inc (PCYC)
2. Pulse Biosciences, Inc. (PLSE)
3. Summit Therapeutics Inc. (SMMT)
Table 1. Insider trading of Pharmacyclics Inc (PCYC) by Zanganeh Mahkam
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-03-11 | PCYC | Sale | 30,000 | 254.12 | 7,623,450 |
| 2015-03-11 | PCYC | Option Ex | 30,000 | 7.19 | 215,700 |
| 2015-03-12 | PCYC | Option Ex | 140,719 | 1.52 | 214,596 |
Table 2. Insider trading of Pulse Biosciences, Inc. (PLSE) by Zanganeh Mahkam
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-11-13 | PLSE | Option Ex | 76,075 | 2.14 | 162,800 |
| 2020-06-23 | PLSE | Buy | 1,193 | 10.70 | 12,767 |
| 2020-06-17 | PLSE | Buy | 7,950 | 7.01 | 55,729 |
| 2017-12-13 | PLSE | Buy | 1,100 | 23.98 | 26,378 |
| 2017-12-11 | PLSE | Buy | 3,000 | 22.76 | 68,289 |
| 2017-12-12 | PLSE | Buy | 1,000 | 23.98 | 23,979 |
| 2017-09-14 | PLSE | Buy | 22,000 | 12.89 | 283,514 |
| 2017-09-18 | PLSE | Buy | 7,775 | 15.02 | 116,788 |
| 2017-08-03 | PLSE | Buy | 20,500 | 23.37 | 479,146 |
| 2017-08-02 | PLSE | Buy | 8,290 | 25.15 | 208,468 |
| 2017-05-09 | PLSE | Buy | 33,760 | 20.16 | 680,500 |
| 2017-05-10 | PLSE | Buy | 5,000 | 21.71 | 108,545 |
| 2017-05-11 | PLSE | Buy | 15,000 | 20.84 | 312,540 |
| 2017-03-17 | PLSE | Buy | 8,960 | 24.00 | 215,004 |
| 2017-03-20 | PLSE | Buy | 9,280 | 22.99 | 213,319 |
| 2017-02-15 | PLSE | Buy | 13,000 | 11.97 | 155,649 |
Table 3. Insider trading of Summit Therapeutics Inc. (SMMT) by Zanganeh Mahkam
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-30 | SMMT | Option Ex | 74,545 | 2.64 | 196,798 |
| 2024-03-26 | SMMT | Buy | 30,000 | 3.75 | 112,500 |
| 2024-03-27 | SMMT | Buy | 80,321 | 3.72 | 298,553 |
| 2023-12-12 | SMMT | Buy | 5,000 | 2.07 | 10,350 |
| 2023-03-08 | SMMT | Buy | 23,527,044 | 1.05 | 24,703,396 |
| 2022-08-16 | SMMT | Buy | 5,809,132 | .97 | 5,634,858 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Zanganeh Mahkam
(Co-Chief Executive Officer of Summit Therapeutics Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.